Objectives of the Study:

# To define, describe, segment, and forecast the global proteomics market by instrumentation technology, reagent, services and software, application, end user, and region.

# To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges).

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.

# To forecast the size of the proteomics market in five main regions along with their respective key countries (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).

# To profile key players in the global proteomics market and comprehensively analyze their core competencies and market shares.

# To track and analyze competitive developments such as acquisitions; product launches; expansions; collaborations, partnerships, & agreements; and R&D activities of the leading players in the proteomics market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731

Research Methodologies Followed for This Research:

Primary Research:

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the proteomics market. The primary sources from the demand side included industry experts, such as researchers and scientists, and industry experts from pharmaceutical & biotechnology companies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

Secondary Research:

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the proteomics market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Expected Revenue Growth:

The proteomics market is projected to reach USD 38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%.

Major Growth Boosters:

Growth in this market is driven by increasing research activity in the area of personalized medicine and drug discovery, increasing R&D expenditure by the pharmaceutical and biotechnology sector, and rising government funding for proteomics.

Critical questions the report answers:

# Where will all these developments take the industry in the long term?
# What are the upcoming trends in the proteomics market?
# Which segment provides the most opportunity for growth?
# Who are the leading vendors operating in this market?
# What are the opportunities for new market entrants?

Geographical Growth Scenario:

North America to dominate the proteomics market during the forecast period

In 2018, North America dominated the global proteomics market, followed by Europe. Increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising demand for high-quality research tools for data reproducibility, and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the factors propelling the growth of the market in the region.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=731

Recent Developments:

# In October 2018, Waters Corporation launched its RenataDX Screening System.

# In October 2018, Thermo Fisher Scientific, Inc. (US) collaborated with Symphogen (Denmark) under which Symphogen will use the Thermo Scientific Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC/MS/MS) system with its BioPharma Option to create, test, and validate platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures.

# In July 2018, Thermo Fisher Scientific, Inc. (US) launched the Quadrupole-Orbitrap Mass Spectrometer.

# In May 2018, Agilent acquired Advanced Analytical Technologies, Inc. (US). This acquisition enhanced Agilent’s technology base to provide customers with a comprehensive set of solutions for next-generation sequencing workflows.

# In May 2018, PerkinElmer acquired Shanghai Spectrum Instruments Co., Ltd. (SSI) (China), one of the leading manufacturers of analytical instruments in China. This will help the firm in building its footprint in China through SSI’s localized leading market position.

Global Leaders:

Prominent players in the proteomics market are Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc.(US), GE Healthcare (US), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Luminex Corporation (US), Bruker Corporation (US), Merck KGaA,(Germany), Waters Corporation (US), PerkinElmer, Inc. (US), Creative Proteomics (US), and Promega Corporation (US).

Read the Detailed Report@
https://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]